Cargando…

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease

Leishmaniasis and Chagas disease cause great impact on social and economic aspects of people living in developing countries. The treatments for these diseases are based on the same regimen for over 40 years, thus, there is an urgent need for the development of new drugs. In this scenario, Asteraceae...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moraes Neto, Roberval Nascimento, Setúbal, Ruth Flávia Barros, Higino, Taciana Mirely Maciel, Brelaz-de-Castro, Maria Carolina Accioly, da Silva, Luís Cláudio Nascimento, Aliança, Amanda Silva dos Santos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530400/ https://www.ncbi.nlm.nih.gov/pubmed/31156427 http://dx.doi.org/10.3389/fphar.2019.00477

Ejemplares similares

The in Vitro Biological Activity of the Brazilian Brown Seaweed Dictyota mertensii against Leishmania amazonensis
por: Aliança, Amanda Silva dos Santos, et al.
Publicado: (2014)

pCramoll and rCramoll as New Preventive Agents against the Oxidative Dysfunction Induced by Hydrogen Peroxide
por: Nascimento da Silva, Luís Cláudio, et al.
Publicado: (2015)

Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
por: Silva, Ana Catarina Cristovão, et al.
Publicado: (2019)

Opinion Article: NK Cells in Cutaneous Leishmaniasis: Protection or Damage?
por: Cavalcante, Marton Kaique de Andrade, et al.
Publicado: (2022)

Chemical Characterization and Leishmanicidal Activity In Vitro and In Silico of Natural Products Obtained from Leaves of Vernonanthura brasiliana (L.) H. Rob (Asteraceae)
por: Fróes, Yuri Nascimento, et al.
Publicado: (2023)

Editorial: Ethnopharmacological Studies for the Development of Drugs With Special Reference to Asteraceae
por: Panda, Sujogya Kumar, et al.
Publicado: (2019)

Editorial: Developing Medicines (Drugs) derived from the Asteraceae—an opportunity in ethnopharmacology, Volume II
por: da Silva, Luis Cláudio Nascimento, et al.
Publicado: (2023)

Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp.
por: Freitas-Silva, Rafael, et al.
Publicado: (2014)

Renal dysfunction in Leishmaniasis and Chagas disease coinfection: a case report
por: de Alcântara, Cid Carlos Soares, et al.
Publicado: (2018)

Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area
por: Guedes, Diego Lins, et al.
Publicado: (2022)

Central and Effector Memory Human CD4(+) and CD8(+) T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes
por: de Oliveira, Beatriz Coutinho, et al.
Publicado: (2023)

FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis
por: Teixeira-Carvalho, Andréa, et al.
Publicado: (2015)

Assessment of the In Vitro Antischistosomal Activities of the Extracts and Compounds from Solidago Microglossa DC (Asteraceae) and Aristolochia Cymbifera Mart. & Zucc. (Aristolochiaceae)
por: Costa, Poliana da Silva, et al.
Publicado: (2020)

Timing of Pharyngeal Swallow Events in Chagas’ Disease
por: dos Santos, Carla Manfredi, et al.
Publicado: (2014)

Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
por: Souto, Eliana B., et al.
Publicado: (2019)

Thymic Exhaustion and Increased Immune Activation Are the Main Mechanisms Involved in Impaired Immunological Recovery of HIV-Positive Patients under ART
por: Dos Santos Guedes, Maria Carolina, et al.
Publicado: (2023)

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target
por: Lazarin-Bidóia, Danielle, et al.
Publicado: (2022)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Agrochemicals against Malaria, Sleeping Sickness, Leishmaniasis and Chagas Disease
por: Witschel, Matthias, et al.
Publicado: (2012)

Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
por: Khare, Shilpi, et al.
Publicado: (2016)

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases
por: J, Brindha, et al.
Publicado: (2021)

Evaluation of Molecular Methods to Identify Chagas Disease and Leishmaniasis in Blood Donation Candidates in Two Brazilian Centers
por: Ferreira, Juliana de Jesus Guimarães, et al.
Publicado: (2023)

Ethyl Acetate Fraction of Punica granatum and Its Galloyl-HHDP-Glucose Compound, Alone or in Combination with Fluconazole, Have Antifungal and Antivirulence Properties against Candida spp.
por: Mendonça, Aline Michelle Silva, et al.
Publicado: (2022)

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
por: Rezende-Oliveira, Karine, et al.
Publicado: (2020)

Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
por: Roquero, Irene, et al.
Publicado: (2019)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

American tegumentary leishmaniasis diagnosis using L. (V.) braziliensis fixed promastigotes: a comparative performance of serological tests and spontaneous cure identification
por: Mendes, Andresa Pereira Oliveira, et al.
Publicado: (2019)

Factors Associated with Visceral Leishmaniasis in the Americas: A Systematic Review and Meta-Analysis
por: Belo, Vinícius Silva, et al.
Publicado: (2013)

Targeting the Immune System with Plant Lectins to Combat Microbial Infections
por: Jandú, Jannyson J. B., et al.
Publicado: (2017)

Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
por: Chevillard, Christophe, et al.
Publicado: (2018)

Variability of Oral and Pharyngeal Transit Between Two Consecutive Swallows in Chagas’ Disease
por: Dantas, Roberto Oliveira, et al.
Publicado: (2013)

Correction: Factors Associated with Visceral Leishmaniasis in the Americas: A Systematic Review and Meta-Analysis
por: Belo, Vinícius Silva, et al.
Publicado: (2013)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Biosynthesis of Galactofuranose in Kinetoplastids: Novel Therapeutic Targets for Treating Leishmaniasis and Chagas' Disease
por: Oppenheimer, Michelle, et al.
Publicado: (2011)

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy
por: Santi, Ana Maria Murta, et al.
Publicado: (2022)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Laryngeal Leishmaniasis
por: Moraes, Bruno Teixeira de, et al.
Publicado: (2012)

Acute micro-outbreak of Chagas disease in the southeastern Amazon: a report of five cases
por: de Brito, Andreza Karoline Souza Barros, et al.
Publicado: (2022)

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis
por: Belo, Vinícius Silva, et al.
Publicado: (2014)

Canine visceral leishmaniasis in an urban setting of Southeastern Brazil: an ecological study involving spatial analysis
por: Teixeira-Neto, Rafael Gonçalves, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u14uoi1l5jm955dg9qjsrm4muc